Chicago Trust CO Na Insulet Corp Transaction History

Chicago Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$127.77 - $221.42 $129,047 - $223,634	1,010 New	1,010 $219,000
Q4 2022 Jan 12, 2023	BUY	$212.22 - $313.46 $180,387 - $266,441	850 New	850 $250,000
Q2 2022 Aug 03, 2022	SELL	$186.4 - $279.02 $260,960 - $390,628	-1,400 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$255.32 - $318.29 $165,958 - $206,888	650 Added 86.67%	1,400 $372,000
Q3 2021 Oct 13, 2021	BUY	$260.36 - $307.27 $195,270 - $230,452	750 New	750 $213,000

613

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Chicago Trust CO Na with notifications on news.